Screener
USANA Health Sciences USNA Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Three months ended / April 4,2026 | Three months ended / March 29,2025 |
|---|---|---|
| Depreciation and amortization | 8,277 | 8,339 |
| Right-of-use asset reduction | 1,512 | 1,906 |
| Loss on sale of property and equipment | 13 | — |
| Equity-based compensation expense | 3,454 | 2,880 |
| Deferred income taxes | 2,108 | 1,355 |
| Inventory write-down | 1,299 | 1,211 |
| Changes in operating assets and liabilities: | ||
| Trade accounts receivable | (5,367) | 1,004 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's stock-based comp?
- USANA Health Sciences (USNA) reported stock-based comp of $3.45M in Q1 2026.
- How has USANA Health Sciences's stock-based comp changed year-over-year?
- USANA Health Sciences's stock-based comp increased by 19.9% year-over-year, from $2.88M to $3.45M.
- What is the long-term trend for USANA Health Sciences's stock-based comp?
- Over 4 years (2021 to 2025), USANA Health Sciences's stock-based comp has grown at a -0.8% compound annual growth rate (CAGR), from $14.3M to $13.83M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about USANA Health Sciences's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude